• LAST PRICE
    0.5030
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.5030
  • Day Range
    ---
  • 52 Week Range
    Low 0.1900
    High 0.5680
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesQRON
Qrons Inc
6.7M
-7.2x
---
United StatesGSTC
GlobeStar Therapeutics Corp
6.7M
-0.9x
---
United StatesWINT
Windtree Therapeutics Inc
6.5M
-0.1x
---
United StatesXTLB
X T L Biopharmaceuticals Ltd
7.0M
-2.3x
---
United StatesATXI
Avenue Therapeutics Inc
7.0M
-0.4x
---
United StatesREVB
Revelation Biosciences Inc
6.1M
-15.7x
---
As of 2023-02-04

Company Information

Qrons Inc. is a biotechnology company. The Company is focused on developing biotech products, treatments and technologies to combat neuronal diseases. It seeks to engage in arrangements with companies and institutions that are developing technologies in the fields of artificial intelligence, machine learning, molecular biology, stem cells and tissue engineering, for deployment in neuronal diseases. The Company has developed two product candidates, QS100TM for treating penetrating brain injuries and QS200TM, for treating concussions and other diffused axonal injuries. Both QS100TM and QS200TM integrate, anti-brain inflammation synthetic hydrogel and modified mesenchymal stem cells (MSCs) and smart synthetic material. Its QS100TM is an injury-specific, three-dimensional (3D) printable, implantable MSCs-synthetic hydrogel to treat penetrating brain injuries and QS200TM is an injectable MSCs-synthetic hydrogel for the treatment of diffused injuries referred to concussions.

Contact Information

Headquarters
28-10 JACKSON AVENUE, #26NLONG ISLAND CITY, NY, United States 11101
Phone
212-945-2080
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.7M
Revenue (TTM)
$0.00
Shares Outstanding
13.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.78
EPS
$-0.07
Book Value
$-0.08
P/E Ratio
-7.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.